176. JAMA. 2018 Jun 19;319(23):2377-2378. doi: 10.1001/jama.2018.5330.Direct-to-Consumer Genetic Testing: The Implications of the US FDA's FirstMarketing Authorization for BRCA Mutation Testing.Gill J(1), Obley AJ(2), Prasad V(1)(3).Author information: (1)Division of Hematology Oncology, Knight Cancer Institute, Oregon Health andScience University, Portland.(2)Section of General Internal Medicine, Veterans Affairs Medical Center,Portland, Oregon.(3)Center for Health Care Ethics, Oregon Health and Science University, Portland.Erratum in    JAMA. 2018 Jul 24;320(4):408.    JAMA. 2018 Jul 24;320(4):408.DOI: 10.1001/jama.2018.5330 PMID: 29800087  [Indexed for MEDLINE]